相似文献
1
Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale.
Angew Chem Int Ed Engl. 2016 Nov 7;55(46):14246-14249. doi: 10.1002/anie.201607380. Epub 2016 Oct 13.
2
Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
Chem Res Toxicol. 2010 Aug 16;23(8):1313-21. doi: 10.1021/tx100023c.
3
DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Biochemistry. 2003 Jan 28;42(3):792-800. doi: 10.1021/bi026614t.
4
Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts.
Chem Biol. 2002 May;9(5):629-38. doi: 10.1016/s1074-5521(02)00134-5.
5
Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
Biochemistry. 2007 Jun 5;46(22):6477-87. doi: 10.1021/bi062291f. Epub 2007 May 12.
6
Recognition of cisplatin adducts by cellular proteins.
Mutat Res. 2001 Jul 1;478(1-2):1-21. doi: 10.1016/s0027-5107(01)00142-7.
7
Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin.
Nature. 1995 Oct 19;377(6550):649-52. doi: 10.1038/377649a0.
8
Long-term, genome-wide kinetic analysis of the effect of the circadian clock and transcription on the repair of cisplatin-DNA adducts in the mouse liver.
J Biol Chem. 2019 Aug 9;294(32):11960-11968. doi: 10.1074/jbc.RA119.009579. Epub 2019 Jun 19.
9
Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Mol Pharm. 2011 Oct 3;8(5):1941-54. doi: 10.1021/mp200309x. Epub 2011 Aug 17.
10
Recognition of platinum-DNA adducts by HMGB1a.
Biochemistry. 2012 Sep 25;51(38):7608-17. doi: 10.1021/bi3008577. Epub 2012 Sep 14.
引用本文的文献
1
NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer.
Elife. 2025 Aug 27;13:RP103904. doi: 10.7554/eLife.103904.
2
3D genome organization shapes DNA damage susceptibility to platinum-based drugs.
Nucleic Acids Res. 2025 May 22;53(10). doi: 10.1093/nar/gkaf315.
3
Perfusion-based ex vivo culture of frozen ovarian cancer tissues with preserved tumor microenvironment.
NPJ Precis Oncol. 2025 May 23;9(1):152. doi: 10.1038/s41698-025-00941-6.
4
MADDD-seq, a novel massively parallel sequencing tool for simultaneous detection of DNA damage and mutations.
Nucleic Acids Res. 2024 Sep 9;52(16):e76. doi: 10.1093/nar/gkae632.
5
Cisplatin in the era of PARP inhibitors and immunotherapy.
Pharmacol Ther. 2024 Jun;258:108642. doi: 10.1016/j.pharmthera.2024.108642. Epub 2024 Apr 16.
6
DNA Damage Atlas: an atlas of DNA damage and repair.
Nucleic Acids Res. 2024 Jan 5;52(D1):D1218-D1226. doi: 10.1093/nar/gkad845.
7
Chem-map profiles drug binding to chromatin in cells.
Nat Biotechnol. 2023 Sep;41(9):1265-1271. doi: 10.1038/s41587-022-01636-0. Epub 2023 Jan 23.
8
Kanamycin and Cisplatin Ototoxicity: Differences in Patterns of Oxidative Stress, Antioxidant Enzyme Expression and Hair Cell Loss in the Cochlea.
Antioxidants (Basel). 2022 Sep 6;11(9):1759. doi: 10.3390/antiox11091759.
9
Nucleotide excision repair: a versatile and smart toolkit.
Acta Biochim Biophys Sin (Shanghai). 2022 May 25;54(6):807-819. doi: 10.3724/abbs.2022054.
10
Current and Future Methodology for Quantitation and Site-Specific Mapping the Location of DNA Adducts.
Toxics. 2022 Jan 19;10(2):45. doi: 10.3390/toxics10020045.
本文引用的文献
1
HMGB1-mediated DNA bending: Distinct roles in increasing p53 binding to DNA and the transactivation of p53-responsive gene promoters.
Biochim Biophys Acta Gene Regul Mech. 2018 Mar;1861(3):200-210. doi: 10.1016/j.bbagrm.2018.02.002. Epub 2018 Feb 6.
2
Nucleotide excision repair is impaired by binding of transcription factors to DNA.
Nature. 2016 Apr 14;532(7598):264-7. doi: 10.1038/nature17661.
3
Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Nature. 2016 Apr 14;532(7598):259-63. doi: 10.1038/nature17437.
4
Differential DNA lesion formation and repair in heterochromatin and euchromatin.
Carcinogenesis. 2016 Feb;37(2):129-38. doi: 10.1093/carcin/bgv247. Epub 2015 Dec 30.
5
Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery.
J Clin Oncol. 2015 Dec 10;33(35):4219-26. doi: 10.1200/JCO.2015.60.7481. Epub 2015 Oct 26.
6
3D-DIP-Chip: a microarray-based method to measure genomic DNA damage.
Sci Rep. 2015 Jan 22;5:7975. doi: 10.1038/srep07975.
7
Binding of kinetically inert metal ions to RNA: the case of platinum(II).
Met Ions Life Sci. 2011;9:347-77. doi: 10.1039/9781849732512-00347.
8
Circadian regulation of DNA excision repair: implications for chrono-chemotherapy.
Cell Cycle. 2009 Jun 1;8(11):1665-7. doi: 10.4161/cc.8.11.8707. Epub 2009 Jun 9.
9
Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.
Biophys J. 2007 Dec 1;93(11):3950-62. doi: 10.1529/biophysj.107.116996. Epub 2007 Aug 17.
10
Direct cellular responses to platinum-induced DNA damage.
Chem Rev. 2007 May;107(5):1387-407. doi: 10.1021/cr068207j. Epub 2007 Apr 25.
Zotero 插件